Amgen Hit With FDA Warning Over Drug-Device Combos
The U.S. Food and Drug Administration on Tuesday released warning letters chastising Amgen Inc. for alleged design shortcomings related to prefilled syringes and Baxter Healthcare Corp. for the way it responded...To view the full article, register now.
Already a subscriber? Click here to view full article